Melatonin Evolan

Melatonin, the active ingredient in Melatonin Evolan, is a melatonin receptor agonist presented as an oral formulation for oral use. It helps regulate the sleep‑wake cycle and is used to support sleep onset in adults who have difficulty falling asleep.

GNH USA supplies Melatonin Evolan as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Melatonin acts on the MT1 and MT2 receptors to influence circadian rhythm disorders.

Insomnia: assists adults in initiating sleep more quickly. Delayed Sleep Phase Disorder: helps shift the sleep window earlier. Jet Lag: facilitates adjustment of the internal clock after rapid time‑zone travel.

Melatonin is generally well tolerated, but adverse reactions can occur.

Common Side Effects: - Headache: mild to moderate discomfort. - Dizziness: transient sensation of light‑headedness. - Daytime sleepiness: occasional lingering drowsiness. - Nausea: mild gastrointestinal upset. - Mood changes: slight irritability or emotional variability.

Serious or Rare Side Effects: - Allergic reaction: rash, itching, swelling, or difficulty breathing. - Worsening depression: increased depressive symptoms in susceptible individuals. - Severe daytime drowsiness: excessive sleepiness affecting daily activities. - Hallucinations: rare visual or auditory disturbances. - Hypotension: unexpected drop in blood pressure.

Before using Melatonin Evolan, consider the following safety measures. - Assess suitability: confirm the sleep disorder and evaluate underlying causes. - Driving caution: avoid operating machinery if daytime drowsiness occurs. - Hepatic impairment: use with caution in patients with liver dysfunction. - Pediatric use: not recommended for children unless specifically prescribed. - Concomitant sedatives: avoid combining with other CNS depressants without medical advice. - Store at ambient temperature: keep in the original pack, protect from moisture and direct sunlight.

Melatonin may interact with other medicines; monitor accordingly.

Major Interactions (Avoid): - CNS depressants: concurrent use with benzodiazepines or barbiturates can enhance sedation. - Anticoagulants: may increase bleeding risk when taken with warfarin. - Immunosuppressants: can reduce the effectiveness of drugs like cyclosporine.

Moderate Interactions (Monitor Closely): - Oral contraceptives: may reduce hormonal contraceptive efficacy. - Antidepressants (SSRIs): potential for increased serotonin syndrome risk. - Caffeine: may counteract melatonin’s sleep‑promoting effect.